Commonwealth Equity Services, Inc - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 106 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 1.31 and the average weighting 0.3%.

Quarter-by-quarter ownership
Commonwealth Equity Services, Inc ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2017$218,000
-4.0%
41,655
+2.2%
0.00%0.0%
Q2 2017$227,000
-32.4%
40,755
+2.0%
0.00%
-50.0%
Q1 2017$336,000
+31.8%
39,955
-0.7%
0.00%0.0%
Q4 2016$255,000
+43.3%
40,2550.0%0.00%
+100.0%
Q3 2016$178,000
+56.1%
40,2550.0%0.00%0.0%
Q2 2016$114,000
+16.3%
40,255
+15.7%
0.00%0.0%
Q1 2016$98,000
-67.8%
34,805
+18.0%
0.00%
-66.7%
Q4 2015$304,000
+3.8%
29,505
+14.8%
0.00%0.0%
Q3 2015$293,000
-21.2%
25,705
+3.2%
0.00%
-25.0%
Q2 2015$372,000
+63.2%
24,905
-1.3%
0.00%
+100.0%
Q1 2015$228,000
-25.5%
25,225
+0.2%
0.00%
-33.3%
Q4 2014$306,000
+9.7%
25,175
-11.7%
0.00%0.0%
Q3 2014$279,000
-75.8%
28,495
-68.5%
0.00%
-78.6%
Q2 2014$1,154,000
+152.0%
90,523
+108.9%
0.01%
+133.3%
Q1 2014$458,000
+215.9%
43,323
+127.7%
0.01%
+200.0%
Q4 2013$145,000
+3.6%
19,023
-1.3%
0.00%0.0%
Q3 2013$140,000
+438.5%
19,273
+15.9%
0.00%
Q2 2013$26,00016,6230.00%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q3 2016
NameSharesValueWeighting ↓
VHCP Management, LLC 1,744,356$18,455,0009.59%
RA Capital Management 4,347,456$45,996,0003.30%
Cormorant Asset Management, LP 1,168,000$12,357,0002.84%
Baker Brothers Advisors 5,867,031$62,073,0000.79%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 907,920$9,606,0000.39%
QVT Financial LP 525,734$5,562,0000.32%
EAM Investors, LLC 114,548$1,212,0000.22%
FRANKLIN STREET ADVISORS INC /NC 93,000$984,0000.20%
THB ASSET MANAGEMENT 301,529$3,190,0000.19%
TPG Group Holdings (SBS) Advisors, Inc. 1,162,269$12,297,0000.13%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders